Cyber Incident Victim: Kracie
Date:
Feb 2022
Location:
Japan
Summary
The company experienced unauthorized access to its internal systems, prompting an immediate investigation which confirmed potential exposure of sensitive personal information. Security measures were swiftly implemented to contain the breach and prevent further unauthorized activity, while external cybersecurity experts assisted in assessing the incident's scope. Affected individuals were notified with guidance on protective steps, and relevant authorities were engaged to address regulatory obligations. The organization reinforced system monitoring and access controls to mitigate future risks, emphasizing transparency throughout the response process.
| CIA Posture | Motives | Tactics, Techniques & Procedures |
|---|---|---|
| Available to members | 0 motives | 0 techniques |
| Threat Actors | Type | Location |
|---|---|---|
| 0 actors | Available to members | Available to members |
Description
On February 9, 2022, Kracie Pharmaceuticals detected unauthorized access to its customer consultation portal systems. The company immediately initiated an internal investigation to assess the nature and scope of the intrusion. Preliminary findings indicated that external attackers potentially compromised personal information belonging to customers who had submitted inquiries through the affected portal. The exposed data included customer names, addresses, telephone numbers, and in some cases email addresses. Kracie confirmed the breach involved systems handling customer communications rather than core manufacturing or financial operations.
Kracie formally reported the incident to Japan's Personal Information Protection Commission and other relevant authorities following confirmation of data exposure. The company issued individual notifications to affected customers through postal mail, detailing the specific categories of their compromised information. A dedicated call center was established to handle customer inquiries regarding the breach. Kracie advised customers to remain vigilant against potential phishing attempts or suspicious communications leveraging the stolen data. The company's investigation remained ongoing to determine the exact intrusion vector and implement additional security measures to prevent recurrence. No evidence of financial information or health data compromise was identified during the initial forensic examination.